Israel Englander Alx Oncology Holdings Inc Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Millennium Management LLC holds 944,084 shares of ALXO stock, worth $415,396. This represents 0.0% of its overall portfolio holdings.

Number of Shares

944,084

Previous 125,000 655.27%

Holding current value

$415,396

Previous $208,000 181.25%

% of portfolio

0.0%

Previous 0.0%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$0.62 - $1.86 $734,716 - $2.2 Million	-1,185,026 Reduced 55.66%	944,084 $585,000
Q4 2024 Feb 14, 2025	BUY	$1.21 - $1.87 $153,350 - $236,996	126,736 Added 6.33%	2,129,110 $3.56 Million
Q3 2024 Nov 14, 2024	BUY	$1.81 - $8.13 $1.23 Million - $5.51 Million	677,178 Added 51.1%	2,002,374 $3.64 Million
Q2 2024 Aug 14, 2024	BUY	$5.84 - $17.56 $7.39 Million - $22.2 Million	1,265,006 Added 2101.69%	1,325,196 $7.99 Million
Q1 2024 May 15, 2024	BUY	$10.95 - $16.79 $659,080 - $1.01 Million	60,190 New	60,190 $671,000
Q2 2023 Aug 14, 2023	BUY	$4.37 - $9.56 $310,387 - $679,018	71,027 Added 134.25%	123,933 $930,000
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $156,120 - $404,463	-34,540 Reduced 39.5%	52,906 $239,000
Q4 2022 Feb 14, 2023	SELL	$9.51 - $12.95 $1.38 Million - $1.87 Million	-144,716 Reduced 62.33%	87,446 $986,000
Q3 2022 Nov 14, 2022	SELL	$8.23 - $15.14 $1.62 Million - $2.98 Million	-197,118 Reduced 45.92%	232,162 $2.22 Million

Others Institutions Holding ALXO

# of Institutions

Shares Held

35.3M

Call Options Held

34K

Put Options Held

36.9K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $17.9M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account